OPEN END TURBO SHORT - SARTORIUS STEDIM BIO Stock

Certificat

DE000MG2R4G4

Real-time Bid/Ask 11:21:50 2024-05-30 EDT
4.11 EUR / 4.14 EUR +2.10% Intraday chart for OPEN END TURBO SHORT - SARTORIUS STEDIM BIO
Current month+63.56%
1 month+139.05%
Date Price Change
24-05-30 4.11 +1.73%
24-05-29 4.04 +4.12%
24-05-28 3.88 +3.19%
24-05-27 3.76 +13.60%
24-05-24 3.31 -0.90%

Delayed Quote Börse Stuttgart

Last update May 30, 2024 at 10:31 am

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying SARTORIUS STEDIM BIOTECH
Issuer Morgan Stanley
WKN MG2R4G
ISINDE000MG2R4G4
Date issued 2024-04-22
Strike 225
Maturity Unlimited
Parity 10 : 1
Emission price 2.48
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 4.36
Lowest since issue 1.16
Spread 0.03
Spread %0.73%

Company Profile

Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany.
Sector
-
More about the company

Ratings for Sartorius Stedim Biotech

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Sartorius Stedim Biotech

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
184.4 EUR
Average target price
248.8 EUR
Spread / Average Target
+34.94%
Consensus